| Literature DB >> 28732529 |
Xingchun Chen1, Lijun Wang2, Jiali Zhou3, Honglong Wu3, Dong Li4, Yanchao Cui4, Binghuai Lu5.
Abstract
BACKGROUND: Bacterial species belonging to the genus Exiguobacterium are facultative anaerobic, non-spore-forming, Gram-positive bacilli, and rarely associated with human infections. Herein, we reported the first case of community-acquired pneumonia (CAP) and bacteremia due to Exiguobacterium spp. in China. CASEEntities:
Keywords: Antibiotics; Bacteremia; Community-acquired pneumonia; Exiguobacterium spp.; Virulence factors; Whole genome sequencing
Mesh:
Substances:
Year: 2017 PMID: 28732529 PMCID: PMC5521131 DOI: 10.1186/s12879-017-2616-1
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Appearances after 24 h and 48 h incubation on Blood agar plates. a Gram staining of the positive blood bottle; b Exiguobacterium AT1b/GX59 after 24 h growth; c and d after 48 h growth
Fig. 2Phylogenetic relatedness of query isolate to closest neighbors based on 16S rRNA homology. Neighbor-joining tree based on 16S rRNA (1,443bases) sequences, showing the phylogenetic relationship between query strain in present study and other related members of the genus Exiguobacterium
Summary of Exiguobacterium AT1b/GX59 strain KEGG annotation
| KEGG (functional category) | GX59 (n) |
|---|---|
| Genetic Information Processing | 418 |
| Environmental Information Processing | 351 |
| Amino acid metabolism | 161 |
| Carbohydrate metabolism | 161 |
| Cellular Processes | 172 |
| Metabolism of cofactors and vitamins | 103 |
| Nucleotide metabolism | 88 |
| Energy metabolism | 80 |
| Human Diseases | 75 |
| Enzyme families | 58 |
| Lipid metabolism | 47 |
| Metabolism of other amino acids | 35 |
| Metabolism of terpenoids and polyketides | 32 |
| Glycan biosynthesis and metabolism | 30 |
| Organismal systems | 31 |
| Xenobiotics biodegradation and metabolism | 25 |
| Biosynthesis of other secondary metabolites | 17 |
| Unclassified | 231 |
Fig. 3Venn diagrams of common- and specific-gene in E. acetylicum DSM 20416, E. aurantiacum DSM 6208, Exiguobacterium sp. AT1b and Exiguobacterium AT1b/GX59 strain in current study
General genome features of the four Exiguobacterium species
| Organism | Source | Size(Mb) | GC% | CDS | No. of tRNAs | No. of contigs | Genome status | GenBank No. |
|---|---|---|---|---|---|---|---|---|
|
| BALF and blood, China | 2.73 | 47 | 2855 | 37 | 21 | Draft | GCA_001908175.1 |
|
| spring water, USA | 2.99 | 48 | 3020 | 68 | / | Complete | CP001615 |
|
| Creamery waste, UK | 3.28 | 47 | 3323 | 69 | 3 | Draft | JNIR00000000 |
|
| Potato wash, UK | 3.04 | 53 | 3067 | 67 | 2 | Draft | JNIQ00000000 |
Summary of reported cases of human infection due to Exiguobacterium spp.
| Reference | 2003 [ | 2006 [ | 2007 [ | 2014 [ | 2007 [ | Our data |
|---|---|---|---|---|---|---|
| Cases number | 1 | 1 | 1 | 1 | 6 | 1 |
| Age(y)/Gender | 55/M | NM/M | 92/F | 66/M | 27/M(1), NM/M(3),neonate(1),55/M(1) | 51/M |
| Community-acquired or hospital acquired | NM | NM | Nosocomial acquisition | Community-acquired | NM | Community-acquired |
| Sources | NM | NM | Catheter-related | Handled the skin of a deer and a wild boar. | NM | Respiratory tract, sugarcane farmer |
| Underlying disease | Alcoholic liver cirrhosis. | NM | Hypertension, hyperuricaemia and Alzheimer’s disease. | Previously healthy | Intravenous drug abuse(1), multiple myeloma(2), suspected infective endocarditis(1), neonate(1), igg kappa multiple myeloma, received local radiotherapy, corticosteroids and infusion chemotherapy(1). | T2DM |
| Presentation | Abdominal pain and diarrhea | NM | 37.4 °C; late increased to 38.6 °C. | Afebrile with no systemic symptoms. Ulcer on a finger with a painful black eschar. | NM(5), febrile at 38.2 °C and experienced rigors after the indwelling central line was flushed(1). | Fever, chills, headache, cough, expectoration, hemoptysis, and dyspnea |
| Diagnosis | Bacteremia | Bacteremia | Bacteremia | Cutaneous infection | Bacteremia | Bacteremia and pneumonia |
| Sources | Bloodstream | Bloodstream | Bloodstream | Skin infection exudate | Bloodstream | Bloodstream and BALF |
| Identification | ||||||
| Commercial identification systems |
|
| Not identified by API Coryne (biomérieux) |
|
|
|
| 16 s rRNA | 99% |
|
|
|
|
|
| AST | NM | NM | Susceptible to penicillins, cephalosporins, Aminoglycosides and quinolones | Susceptible to penicillin, cefotaxime, imipenem, levofloxacin, vancomycin, clindamycin, erythromycin, gentamicin, doxycycline, linezolid, and daptomycin. | Susceptible to ampicillin, cefotaxime, chloramphenicol, ciprofloxacin, clindamycin, erythromycin, gentamicin, penicillin, rifampicin, teicoplanin, tetracycline and trimethoprim | Susceptible to penicillin, meropenem, gentamicin, ciprofloxacin, rifampin, and vancomycin, Resistant to tetracycline, erythromycin, clindamycin |
| Antibiotic therapy | NM | NM | Intravenous cefuroxime treatment was initiated; afterwards, cefuroxime | Ciprofloxacin for 10 days. | 6th patient: intravenous ceftazidime and teicoplanin for the following 3 days, the fever persisted. Others: unknown | Imipenem, moxifloxacin and voriconazole |
| Outcome | Recovered | NM | Recovered | Recovered | Recovered | Died |
F Female, M Male, NM Not mentioned, AST Antimicrobial Susceptibility Testing